NSCLC根治性放疗后肺灌注的时间与剂量相关变化
本研究前瞻性纳入58例接受IMRT且放疗剂量至少60 Gy的NSCLC患者,在放疗前及放疗后系列行肺灌注SPECT/CT,分析区域肺灌注变化与区域剂量的关系。结果显示灌注变化与剂量相关,放疗后3、6、12个月观察到剂量依赖性区域灌注下降。发生放射性肺炎的患者在高剂量肺区域灌注下降更大,而低剂量区域反而出现灌注增加。
要点
- 放疗后3、6、12个月观察到剂量依赖性区域肺灌注下降。
- 发生放射性肺炎者高剂量区灌注下降更大,低剂量区灌注增加。
- 灌注动态变化可能对预测放射性肺炎有预后价值。
核心结论
- IMRT后至12个月,SPECT显示进行性剂量依赖性肺灌注丢失。
- 灌注动态变化可能对预测NSCLC患者IMRT后放射性肺炎具有预后价值。
研究设计与样本
- 前瞻性研究纳入58例接受放化疗且放疗剂量至少60 Gy的NSCLC患者。
- 放疗前及放疗后系列行肺灌注SPECT/CT,分析区域灌注变化与区域剂量的相关性。
- 毒性结局为放射性肺炎CTC 2-5级。
主要发现
- 灌注变化与剂量相关,放疗后3、6、12个月观察到剂量依赖性区域灌注下降。
- 每剂量组相对灌注丢失在放疗后1个月为4%、3个月为14%、6个月为13%、12个月为21%。
- 发生放射性肺炎的患者高剂量肺区域灌注下降大于无放射性肺炎者。
- 发生放射性肺炎的患者低剂量区域反而出现灌注增加。
临床怎么用
- 可利用SPECT/CT肺灌注系列监测识别高剂量区灌注下降明显、放射性肺炎风险较高的NSCLC患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To examine radiation-induced changes in regional lung perfusion per dose level in 58 non-small-cell lung cancer (NSCLC) patients treated with intensity-modulated radiotherapy (IMRT). MATERIAL AND METHODS: NSCLC patients receiving chemo-radiotherapy (RT) of minimum 60 Gy were included prospectively in the study. Lung perfusion single-photon emission computed tomography (SPECT/CT) was performed before and serially after RT. Changes (relative to baseline, %) in regional lung perfusion were correlated with regional dose. Toxicity outcome was radiation pneumonitis (RP) CTC grades 2-5. RESULTS: Perfusion changes were associated with dose. Dose-dependent reduction in regional perfusion was observed at 3, 6 and 12 months of follow-up. Relative perfusion loss per dose bin was 4% at 1 month, 14% at 3 months, 13% at 6 months and 21% at 12 months after RT. In patients with RP, perfusion reduction was larger in high dose lung regions, compared to those without RP. Low dose regions, on the contrary, revealed perfusion gain in the patients with RP. CONCLUSION: Progressive dose dependent perfusion loss is manifested on SPECT up to 12 months following IMRT. These findings suggest that the dynamic change in perfusion may have prognostic value in predicting radiation pneumonitis in NSCLC patients treated with IMRT.
引用
- Farr KP, Khalil AA, Møller DS, et al. Time and dose-related changes in lung perfusion after definitive radiotherapy for NSCLC. Radiother Oncol. 2017. PMID: 29203289. doi:10.1016/j.radonc.2017.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。